Sales & Marketing News | pharmaphorum

News

FDA starts speedy review of Imfinzi in bladder cancer

AstraZeneca is closing on FDA approval of a new bladder cancer indication for Imfinzi that could help to fend off encroachment from MSD's Keytruda.

News

FDA nominee Overton dodges questions on Trump influence

Trump's FDA nominee Heidi Overton was quizzed on a range of issues at her Senate hearing, including vaccines, the abortion pill, and agency reforms.

News

Lilly's rival to Novo's new Awiqli insulin gets FDA approval

The FDA has approved Eli Lilly's once-weekly basal insulin product Onswik, setting up a market tussle with Novo's recently launched Awiqli.

News

Grail cancer test gets lukewarm backing from FDA adcomm

FDA expert advisors voted in favour of Grail's Galleri blood test for detecting multiple cancers, but some expressed misgivings about its efficacy.

News

Pharma leaders urge Europe to halt 'slow agony' of decline

Europe's top pharma firms have called on governments to take action to change the region's story from one of decay to one of "renewal and resilience."

News

UK first country to launch CSL's trivalent flu shot Aujemflu

CSL Seqirus' recently approved trivalent, cell-based influenza vaccine Aujemflu will be part of the UK's 2027/28 immunisation campaign.

FDA starts speedy review of Imfinzi in bladder cancer

FDA nominee Overton dodges questions on Trump influence

Lilly's rival to Novo's new Awiqli insulin gets FDA approval

Grail cancer test gets lukewarm backing from FDA adcomm

Pharma leaders urge Europe to halt 'slow agony' of decline

UK first country to launch CSL's trivalent flu shot Aujemflu

On GDF-15 neutralisation and cachexia, with CatalYm

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks